What is he best known for?
The fields of study he is best known for:
- Immune system
- Internal medicine
- Gene
Thomas J. Scriba mostly deals with Tuberculosis, Immunology, Mycobacterium tuberculosis, Vaccination and Tuberculosis vaccines.
Thomas J. Scriba works on Tuberculosis which deals in particular with BCG vaccine.
His studies examine the connections between Immunology and genetics, as well as such issues in Virology, with regards to Immunity.
His biological study spans a wide range of topics, including Seroconversion, Antigen and Cohort.
His Vaccination study combines topics in areas such as Inflammation and Myeloid.
His study explores the link between Tuberculosis vaccines and topics such as Clinical trial that cross with problems in Adverse effect.
His most cited work include:
- Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial (729 citations)
- Identifying specificity groups in the T cell receptor repertoire (403 citations)
- A blood RNA signature for tuberculosis disease risk: a prospective cohort study. (397 citations)
What are the main themes of his work throughout his whole career to date?
Thomas J. Scriba mainly investigates Tuberculosis, Immunology, Mycobacterium tuberculosis, Immune system and Vaccination.
Thomas J. Scriba has researched Tuberculosis in several fields, including Internal medicine, Disease and Cohort.
His Immunology study integrates concerns from other disciplines, such as Cytotoxic T cell and Virology.
His studies in Mycobacterium tuberculosis integrate themes in fields like Innate immune system, Immunopathology and Immunity.
He has included themes like Tumor necrosis factor alpha, Whole blood and Cytokine in his Immune system study.
Thomas J. Scriba has included themes like Adverse effect and Randomized controlled trial in his Vaccination study.
He most often published in these fields:
- Tuberculosis (68.07%)
- Immunology (61.34%)
- Mycobacterium tuberculosis (50.00%)
What were the highlights of his more recent work (between 2019-2021)?
- Tuberculosis (68.07%)
- Immunology (61.34%)
- Mycobacterium tuberculosis (50.00%)
In recent papers he was focusing on the following fields of study:
His primary scientific interests are in Tuberculosis, Immunology, Mycobacterium tuberculosis, Immune system and Disease.
His biological study spans a wide range of topics, including MEDLINE, Environmental health, Immunopathology, Biomarker and Cohort.
His research on Immunology frequently connects to adjacent areas such as Respiratory tract.
His Mycobacterium tuberculosis research includes elements of Chemokine, T cell, Area under the curve and Antigen.
His Immune system study also includes fields such as
- Tumor necrosis factor alpha, which have a strong connection to CD8 and Molecular biology,
- Gene, which have a strong connection to Epitope and Human leukocyte antigen.
Thomas J. Scriba usually deals with Disease and limits it to topics linked to Asymptomatic and CD3.
Between 2019 and 2021, his most popular works were:
- Analyzing the Mycobacterium tuberculosis immune response by T-cell receptor clustering with GLIPH2 and genome-wide antigen screening. (36 citations)
- RISK6, a 6-gene transcriptomic signature of TB disease risk, diagnosis and treatment response (16 citations)
- S100A8/A9 regulates CD11b expression and neutrophil recruitment during chronic tuberculosis (13 citations)
In his most recent research, the most cited papers focused on:
- Immune system
- Gene
- Internal medicine
Thomas J. Scriba mainly focuses on Mycobacterium tuberculosis, Tuberculosis, Immunology, Immune system and Disease.
His work in Mycobacterium tuberculosis is not limited to one particular discipline; it also encompasses Genome.
His work carried out in the field of Tuberculosis brings together such families of science as Biomarker and Immunopathology.
His Immunology study focuses on Vaccination in particular.
His Immune system research is multidisciplinary, relying on both Tumor necrosis factor alpha, Gene and Antigen.
His Disease research is multidisciplinary, incorporating elements of Oncology, Venous blood, Positron emission tomography, Subclinical infection and Cohort.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
